Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia
Hepatitis C virus (HCV) infection is one of the leading risk factors for end-stage liver disease development worldwide. This RNA virus displays high genetic diversity with 8 genotypes and 96 subgenotypes with heterogeneous geographical distribution around the world. In this study, we carried out an...
- Autores:
-
Lopez Osorio, Maria C.
Usme Ciro, José Aldemar
Martinez, Jose W.
Peláez Carvajal, Dioselina
Hernandez, Javier
Hoyos, Sergio
Restrepo, Juan C.
Navas, Maria Cristina
- Tipo de recurso:
- Article of investigation
- Fecha de publicación:
- 2022
- Institución:
- Universidad Cooperativa de Colombia
- Repositorio:
- Repositorio UCC
- Idioma:
- OAI Identifier:
- oai:repository.ucc.edu.co:20.500.12494/46184
- Acceso en línea:
- https://hdl.handle.net/20.500.12494/46184
- Palabra clave:
- Virus de hepatitis C
Epidemiología
Diversidad genética
Evolución
Infección
Hepatitis C virus
Epidemiology
Genetic diversity
Evolution
Infection
- Rights
- openAccess
- License
- Atribución – No comercial – Compartir igual
id |
COOPER2_55a1329f7ebade837d979d0e00b1863f |
---|---|
oai_identifier_str |
oai:repository.ucc.edu.co:20.500.12494/46184 |
network_acronym_str |
COOPER2 |
network_name_str |
Repositorio UCC |
repository_id_str |
|
dc.title.spa.fl_str_mv |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
title |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
spellingShingle |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia Virus de hepatitis C Epidemiología Diversidad genética Evolución Infección Hepatitis C virus Epidemiology Genetic diversity Evolution Infection |
title_short |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
title_full |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
title_fullStr |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
title_full_unstemmed |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
title_sort |
Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia |
dc.creator.fl_str_mv |
Lopez Osorio, Maria C. Usme Ciro, José Aldemar Martinez, Jose W. Peláez Carvajal, Dioselina Hernandez, Javier Hoyos, Sergio Restrepo, Juan C. Navas, Maria Cristina |
dc.contributor.author.none.fl_str_mv |
Lopez Osorio, Maria C. Usme Ciro, José Aldemar Martinez, Jose W. Peláez Carvajal, Dioselina Hernandez, Javier Hoyos, Sergio Restrepo, Juan C. Navas, Maria Cristina |
dc.subject.spa.fl_str_mv |
Virus de hepatitis C Epidemiología Diversidad genética Evolución Infección |
topic |
Virus de hepatitis C Epidemiología Diversidad genética Evolución Infección Hepatitis C virus Epidemiology Genetic diversity Evolution Infection |
dc.subject.other.spa.fl_str_mv |
Hepatitis C virus Epidemiology Genetic diversity Evolution Infection |
description |
Hepatitis C virus (HCV) infection is one of the leading risk factors for end-stage liver disease development worldwide. This RNA virus displays high genetic diversity with 8 genotypes and 96 subgenotypes with heterogeneous geographical distribution around the world. In this study, we carried out an active case finding of individuals with a history of transfusion events before 1996 in three cities in Colombia. Then, the characterization of the HCV genotypes, subgenotypes, and resistance associate substitutions (RAS) was performed in samples positives for antibodies anti-HCV + from this study population. In addition, samples from PWID and patients with end-stage liver disease submitted to liver transplantation were included in the phylogenetic and RAS analysis. The 5′UTR, NS5A, and NS5B regions of the HCV genome were amplified in serum or liver explants samples. After the edition, assembly, and alignment of the sequences, genotyping through phylogenetic analysis was performed using IQTREE V2.0.5 based on the maximum likelihood approach. The identification of RAS was carried out by alignments based on the reference sequence (GenBank NC_004102). Two hundred sixty individuals with blood transfusion events before 1996 were recruited. The seroprevalence of antibodies anti-HCV was 2.69% in this population. The HCV genotypes 1, 2, and 4 and subgenotypes 1a, 1b, 2a, 4a and 4d were characterized in samples of the study populations. Three RAS (Q30R, C316N, and Y93H) were identified in samples obtained from 2 individuals who received blood transfusion before 1996 and without previous antiviral treatment and 6 samples obtained from patients with end-stage liver disease. Among the 20 samples analyzed, the HCV genotype 1, subgenotype 1b, was the most frequent (60%). We report the first characterization of HCV subgenotypes 4a and 4d and the first RAS identification in patients in Colombia. |
publishDate |
2022 |
dc.date.accessioned.none.fl_str_mv |
2022-08-19T23:58:58Z |
dc.date.available.none.fl_str_mv |
2022-08-19T23:58:58Z |
dc.date.issued.none.fl_str_mv |
2022-06-10 |
dc.type.none.fl_str_mv |
Artículos Científicos |
dc.type.coar.none.fl_str_mv |
http://purl.org/coar/resource_type/c_2df8fbb1 |
dc.type.coarversion.none.fl_str_mv |
http://purl.org/coar/version/c_970fb48d4fbd8a85 |
dc.type.driver.none.fl_str_mv |
info:eu-repo/semantics/article |
dc.type.version.none.fl_str_mv |
info:eu-repo/semantics/publishedVersion |
format |
http://purl.org/coar/resource_type/c_2df8fbb1 |
status_str |
publishedVersion |
dc.identifier.issn.spa.fl_str_mv |
0168-1702 |
dc.identifier.uri.spa.fl_str_mv |
10.1016/j.virusres.2022.198847 |
dc.identifier.uri.none.fl_str_mv |
https://hdl.handle.net/20.500.12494/46184 |
dc.identifier.bibliographicCitation.spa.fl_str_mv |
Lopez-Osorio MC, Usme-Ciro JA, Martínez JW, Peláez-Carvajal D, Hernández J, Hoyos S, Restrepo JC, Navas MC. Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia. Virus Res. 2022 Sep;318:198847. doi: 10.1016/j.virusres.2022.198847.https://repository.ucc.edu.co/handle/20.500.12494/46184 |
identifier_str_mv |
0168-1702 10.1016/j.virusres.2022.198847 Lopez-Osorio MC, Usme-Ciro JA, Martínez JW, Peláez-Carvajal D, Hernández J, Hoyos S, Restrepo JC, Navas MC. Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia. Virus Res. 2022 Sep;318:198847. doi: 10.1016/j.virusres.2022.198847.https://repository.ucc.edu.co/handle/20.500.12494/46184 |
url |
https://hdl.handle.net/20.500.12494/46184 |
dc.relation.isversionof.spa.fl_str_mv |
https://www.sciencedirect.com/science/article/abs/pii/S0168170222001757?via%3Dihub |
dc.relation.conferenceplace.spa.fl_str_mv |
Paises Bajos |
dc.relation.ispartofjournal.spa.fl_str_mv |
Virus Research |
dc.relation.references.spa.fl_str_mv |
Aldunate, F., Echeverría, N., Chiodi, D., Lopez, ´ P., S´ anchez-Ciceron, ´ A., Fajardo, A., ´ Sonora, ˜ M., Cristina, J., Hern´ andez, N., Moreno, P., 2018. Pretreatment Hepatitis C Virus NS5A/NS5B resistance-associated substitutions in genotype 1 uruguayan infected patients. Dis Markers 14, 2514901. https://doi.org/10.1155/2018/ 2514901, 2018. Arroyave, J., Alvarez, ´ C., Correa, G., Balc´ azar, N., Arbelaez, M.P., Navas, M.C., Cristina, M., 2014. Hepatitis C infections among individuals who received transfusions prior to 1994 in antioquia. Colombia. Rev. Colomb. Gastroenterol. 29, 383–389. Bartenschlager, R., Lohmann, V., Penin, F., 2013. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11, 482–496. https://doi.org/10.1038/nrmicro3046. Beltrˆ an, M., Navas, M.-C., De la Hoz, F., Mercedes Munoz, ˜ M., Jaramillo, S., Estrada, C., Del Pilar Cort´ es, L., Arbelˆ aez, M.P., Donado, J., Barco, G., Luna, M., Uribe, G.A., de Maldonado, A., Restrepo, J.C., Correa, G., Borda, P., Rey, G., de Neira, M., Estrada, A., Yepes, S., Beltrˆ an, O., Pacheco, J., Villegas, I., Boshell, J., 2005. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 34 (2), S33–S38. Suppl. Bhattacharjee, C., Singh, M., Das, D., Chaudhuri, S., Mukhopadhyay, A., 2021. Current therapeutics against HCV. Virusdisease. https://doi.org/10.1007/s13337-021- 00697-0, 1–16. Bolcic, F., Jones, L.R., Laufer, N., Quarleri, J., 2011. Molecular characterization of hepatitis C virus genotype 4 sequences in HIV-coinfected patients from Argentina. J. Med. Virol. 83, 935–940. https://doi.org/10.1002/jmv.22068. Chaiwong, S., Sistayanarain, A., 2016. Characterization of partial NS5B region among hepatitis C virus genotype 6 subgenotypes isolated from Thai blood donors: characterization of NS5B among hepatitis C Virus genotype 6. J. Med. Virol. 88, 1785–1790. https://doi.org/10.1002/jmv.24536. Chan, S.W., McOmish, F., Holmes, E.C., Dow, B., Peutherer, J.F., Follett, E., Yap, P.L., Simmonds, P., 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73 (Pt 5), 1131–1141. https://doi. org/10.1099/0022-1317-73-5-1131. Cooper, C.L., Read, D., Vachon, M.-L., Conway, B., Wong, A., Ramji, A., Borgia, S., Tam, E., Barrett, L., Smyth, D., Feld, J.J., Lee, S., CANUHC, C., 2020. Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants. BMC Public Health 20, 1345. https://doi.org/10.1186/s12889-020-09464-0. di Filippo, D., Cortes-Mancera, F., Beltran, M., Arbelaez, M.P., Jaramillo, S., Restrepo, J. C., Correa, G., Navas, M.-C., 2012a. Molecular characterization of hepatitis c virus in multi-transfused Colombian patients. Virol. J. 9, 242. https://doi.org/10.1186/ 1743-422X-9-242. Ef, D., Pr, H., Jj, O., Lk, N., 2015. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatol. Baltim. 61 https://doi.org/10.1002/hep.27375. Gomez-Escolar, ´ L., García Herola, A., Saez ´ Lloret, I., S´ anchez Ruano, F., Clemente Paulino, I., Quílez Ivorra, C., Almenta Saavedra, I., Martínez P´ erez, D., Valverde de la Osa, J., 2018 Sep. Screening of hepatitis C virus infection in adult general population in Spain. Eur. J. Gastroenterol. Hepatol. 30 (9), 1077–1081. https://doi. org/10.1097/MEG.0000000000001190. Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., Razavi, H., 2014. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45–S57. https://doi.org/10.1016/j.jhep.2014.07.027. Hall, T., 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41, 95–98. Hedskog, C., Parhy, B., Chang, S., Zeuzem, S., Moreno, C., Shafran, S.D., Borgia, S.M., Asselah, T., Alric, L., Abergel, A., Chen, J.-J., Collier, J., Kapoor, D., Hyland, R.H., Simmonds, P., Mo, H., Svarovskaia, E.S., 2019. Identification of 19 novel hepatitis c virus subgenotypes-further expanding HCV classification. Open Forum Infect. Dis. 6, ofz076. https://doi.org/10.1093/ofid/ofz076. Hepatitis C. World Health Organization, 2021. https://www.who.int/news-room/f act-sheets/detail/hepatitis-c. Kai, Y., Hikita, H., Morishita, N., Murai, K., Nakabori, T., Iio, S., Hagiwara, H., Imai, Y., Tamura, S., Tsutsui, S., Naito, M., Nishiuchi, M., Kondo, Y., Kato, T., Suemizu, H., Yamada, R., Oze, T., Yakushijin, T., Hiramatsu, N., Sakamori, R., Tatsumi, T., Takehara, T., 2017. Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment. Sci. Rep. 7 https://doi.org/10.1038/srep41660. |
dc.rights.license.none.fl_str_mv |
Atribución – No comercial – Compartir igual |
dc.rights.accessrights.none.fl_str_mv |
info:eu-repo/semantics/openAccess |
dc.rights.coar.none.fl_str_mv |
http://purl.org/coar/access_right/c_abf2 |
rights_invalid_str_mv |
Atribución – No comercial – Compartir igual http://purl.org/coar/access_right/c_abf2 |
eu_rights_str_mv |
openAccess |
dc.format.extent.spa.fl_str_mv |
198847 |
dc.coverage.temporal.spa.fl_str_mv |
318 |
dc.publisher.spa.fl_str_mv |
Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Medicina, Santa Marta Dr. Esteban Domingo |
dc.publisher.program.spa.fl_str_mv |
Medicina |
dc.publisher.place.spa.fl_str_mv |
Santa Marta |
institution |
Universidad Cooperativa de Colombia |
bitstream.url.fl_str_mv |
https://repository.ucc.edu.co/bitstreams/1e2e47d0-90e1-4756-8316-695b5fa724bc/download https://repository.ucc.edu.co/bitstreams/5facfb08-e4dc-452c-9d36-392e9475fefb/download https://repository.ucc.edu.co/bitstreams/652d4dc3-7e4f-45a7-8c49-fa14ff1a9d52/download https://repository.ucc.edu.co/bitstreams/f31d20ce-50d7-4344-b7c4-197eb2cf9e06/download https://repository.ucc.edu.co/bitstreams/3e480bdc-9805-43b7-850f-349d56949482/download https://repository.ucc.edu.co/bitstreams/7af445a7-cae4-4b74-9b51-4d9328a51d56/download https://repository.ucc.edu.co/bitstreams/ec9225f1-664f-49d7-886e-347d1dd53886/download |
bitstream.checksum.fl_str_mv |
193691fdd55e83b5e42bd163d8138dc7 aeded09cc2c681c17fa50dbf22fbc6f7 8a4605be74aa9ea9d79846c1fba20a33 02cda3a98ebd320b62f3837468b20046 680e17ded7c1cdac78327cae8b2dfa1a bf30c9eeff14f64ddcb81b82f96b1ebe 53605d5d528f120ea847fce1283da1b8 |
bitstream.checksumAlgorithm.fl_str_mv |
MD5 MD5 MD5 MD5 MD5 MD5 MD5 |
repository.name.fl_str_mv |
Repositorio Institucional Universidad Cooperativa de Colombia |
repository.mail.fl_str_mv |
bdigital@metabiblioteca.com |
_version_ |
1811565543114670080 |
spelling |
Lopez Osorio, Maria C.Usme Ciro, José AldemarMartinez, Jose W.Peláez Carvajal, DioselinaHernandez, JavierHoyos, SergioRestrepo, Juan C.Navas, Maria Cristina3182022-08-19T23:58:58Z2022-08-19T23:58:58Z2022-06-100168-170210.1016/j.virusres.2022.198847https://hdl.handle.net/20.500.12494/46184Lopez-Osorio MC, Usme-Ciro JA, Martínez JW, Peláez-Carvajal D, Hernández J, Hoyos S, Restrepo JC, Navas MC. Genetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in Colombia. Virus Res. 2022 Sep;318:198847. doi: 10.1016/j.virusres.2022.198847.https://repository.ucc.edu.co/handle/20.500.12494/46184Hepatitis C virus (HCV) infection is one of the leading risk factors for end-stage liver disease development worldwide. This RNA virus displays high genetic diversity with 8 genotypes and 96 subgenotypes with heterogeneous geographical distribution around the world. In this study, we carried out an active case finding of individuals with a history of transfusion events before 1996 in three cities in Colombia. Then, the characterization of the HCV genotypes, subgenotypes, and resistance associate substitutions (RAS) was performed in samples positives for antibodies anti-HCV + from this study population. In addition, samples from PWID and patients with end-stage liver disease submitted to liver transplantation were included in the phylogenetic and RAS analysis. The 5′UTR, NS5A, and NS5B regions of the HCV genome were amplified in serum or liver explants samples. After the edition, assembly, and alignment of the sequences, genotyping through phylogenetic analysis was performed using IQTREE V2.0.5 based on the maximum likelihood approach. The identification of RAS was carried out by alignments based on the reference sequence (GenBank NC_004102). Two hundred sixty individuals with blood transfusion events before 1996 were recruited. The seroprevalence of antibodies anti-HCV was 2.69% in this population. The HCV genotypes 1, 2, and 4 and subgenotypes 1a, 1b, 2a, 4a and 4d were characterized in samples of the study populations. Three RAS (Q30R, C316N, and Y93H) were identified in samples obtained from 2 individuals who received blood transfusion before 1996 and without previous antiviral treatment and 6 samples obtained from patients with end-stage liver disease. Among the 20 samples analyzed, the HCV genotype 1, subgenotype 1b, was the most frequent (60%). We report the first characterization of HCV subgenotypes 4a and 4d and the first RAS identification in patients in Colombia.https://scienti.minciencias.gov.co/cvlac/visualizador/generarCurriculoCv.do?cod_rh=00003185070000-0002-8093-0544https://scienti.minciencias.gov.co/gruplac/jsp/visualiza/visualizagr.jsp?nro=00000000008981jose.usmec@campusucc.edu.cohttps://scholar.google.com.co/citations?user=cU2KyT4AAAAJ&hl=en198847Universidad Cooperativa de Colombia, Facultad de Ciencias de la Salud, Medicina, Santa MartaDr. Esteban DomingoMedicinaSanta Martahttps://www.sciencedirect.com/science/article/abs/pii/S0168170222001757?via%3DihubPaises BajosVirus ResearchAldunate, F., Echeverría, N., Chiodi, D., Lopez, ´ P., S´ anchez-Ciceron, ´ A., Fajardo, A., ´ Sonora, ˜ M., Cristina, J., Hern´ andez, N., Moreno, P., 2018. Pretreatment Hepatitis C Virus NS5A/NS5B resistance-associated substitutions in genotype 1 uruguayan infected patients. Dis Markers 14, 2514901. https://doi.org/10.1155/2018/ 2514901, 2018.Arroyave, J., Alvarez, ´ C., Correa, G., Balc´ azar, N., Arbelaez, M.P., Navas, M.C., Cristina, M., 2014. Hepatitis C infections among individuals who received transfusions prior to 1994 in antioquia. Colombia. Rev. Colomb. Gastroenterol. 29, 383–389.Bartenschlager, R., Lohmann, V., Penin, F., 2013. The molecular and structural basis of advanced antiviral therapy for hepatitis C virus infection. Nat. Rev. Microbiol. 11, 482–496. https://doi.org/10.1038/nrmicro3046.Beltrˆ an, M., Navas, M.-C., De la Hoz, F., Mercedes Munoz, ˜ M., Jaramillo, S., Estrada, C., Del Pilar Cort´ es, L., Arbelˆ aez, M.P., Donado, J., Barco, G., Luna, M., Uribe, G.A., de Maldonado, A., Restrepo, J.C., Correa, G., Borda, P., Rey, G., de Neira, M., Estrada, A., Yepes, S., Beltrˆ an, O., Pacheco, J., Villegas, I., Boshell, J., 2005. Hepatitis C virus seroprevalence in multi-transfused patients in Colombia. J. Clin. Virol. Off. Publ. Pan Am. Soc. Clin. Virol. 34 (2), S33–S38. Suppl.Bhattacharjee, C., Singh, M., Das, D., Chaudhuri, S., Mukhopadhyay, A., 2021. Current therapeutics against HCV. Virusdisease. https://doi.org/10.1007/s13337-021- 00697-0, 1–16.Bolcic, F., Jones, L.R., Laufer, N., Quarleri, J., 2011. Molecular characterization of hepatitis C virus genotype 4 sequences in HIV-coinfected patients from Argentina. J. Med. Virol. 83, 935–940. https://doi.org/10.1002/jmv.22068.Chaiwong, S., Sistayanarain, A., 2016. Characterization of partial NS5B region among hepatitis C virus genotype 6 subgenotypes isolated from Thai blood donors: characterization of NS5B among hepatitis C Virus genotype 6. J. Med. Virol. 88, 1785–1790. https://doi.org/10.1002/jmv.24536.Chan, S.W., McOmish, F., Holmes, E.C., Dow, B., Peutherer, J.F., Follett, E., Yap, P.L., Simmonds, P., 1992. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J. Gen. Virol. 73 (Pt 5), 1131–1141. https://doi. org/10.1099/0022-1317-73-5-1131.Cooper, C.L., Read, D., Vachon, M.-L., Conway, B., Wong, A., Ramji, A., Borgia, S., Tam, E., Barrett, L., Smyth, D., Feld, J.J., Lee, S., CANUHC, C., 2020. Hepatitis C virus infection characteristics and treatment outcomes in Canadian immigrants. BMC Public Health 20, 1345. https://doi.org/10.1186/s12889-020-09464-0.di Filippo, D., Cortes-Mancera, F., Beltran, M., Arbelaez, M.P., Jaramillo, S., Restrepo, J. C., Correa, G., Navas, M.-C., 2012a. Molecular characterization of hepatitis c virus in multi-transfused Colombian patients. Virol. J. 9, 242. https://doi.org/10.1186/ 1743-422X-9-242.Ef, D., Pr, H., Jj, O., Lk, N., 2015. Clinical evidence and bioinformatics characterization of potential hepatitis C virus resistance pathways for sofosbuvir. Hepatol. Baltim. 61 https://doi.org/10.1002/hep.27375.Gomez-Escolar, ´ L., García Herola, A., Saez ´ Lloret, I., S´ anchez Ruano, F., Clemente Paulino, I., Quílez Ivorra, C., Almenta Saavedra, I., Martínez P´ erez, D., Valverde de la Osa, J., 2018 Sep. Screening of hepatitis C virus infection in adult general population in Spain. Eur. J. Gastroenterol. Hepatol. 30 (9), 1077–1081. https://doi. org/10.1097/MEG.0000000000001190.Gower, E., Estes, C., Blach, S., Razavi-Shearer, K., Razavi, H., 2014. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45–S57. https://doi.org/10.1016/j.jhep.2014.07.027.Hall, T., 1999. BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucl. Acids Symp. Ser. 41, 95–98.Hedskog, C., Parhy, B., Chang, S., Zeuzem, S., Moreno, C., Shafran, S.D., Borgia, S.M., Asselah, T., Alric, L., Abergel, A., Chen, J.-J., Collier, J., Kapoor, D., Hyland, R.H., Simmonds, P., Mo, H., Svarovskaia, E.S., 2019. Identification of 19 novel hepatitis c virus subgenotypes-further expanding HCV classification. Open Forum Infect. Dis. 6, ofz076. https://doi.org/10.1093/ofid/ofz076.Hepatitis C. World Health Organization, 2021. https://www.who.int/news-room/f act-sheets/detail/hepatitis-c.Kai, Y., Hikita, H., Morishita, N., Murai, K., Nakabori, T., Iio, S., Hagiwara, H., Imai, Y., Tamura, S., Tsutsui, S., Naito, M., Nishiuchi, M., Kondo, Y., Kato, T., Suemizu, H., Yamada, R., Oze, T., Yakushijin, T., Hiramatsu, N., Sakamori, R., Tatsumi, T., Takehara, T., 2017. Baseline quasispecies selection and novel mutations contribute to emerging resistance-associated substitutions in hepatitis C virus after direct-acting antiviral treatment. Sci. Rep. 7 https://doi.org/10.1038/srep41660.Virus de hepatitis CEpidemiologíaDiversidad genéticaEvoluciónInfecciónHepatitis C virusEpidemiologyGenetic diversityEvolutionInfectionGenetic diversity of hepatitis C virus and resistance associated substitutions to direct-acting antiviral treatment in ColombiaArtículos Científicoshttp://purl.org/coar/resource_type/c_2df8fbb1http://purl.org/coar/version/c_970fb48d4fbd8a85info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionAtribución – No comercial – Compartir igualinfo:eu-repo/semantics/openAccesshttp://purl.org/coar/access_right/c_abf2PublicationORIGINAL37. Genetic diversity of hepatitis C virus. Lopez-Osorio et al 2022.pdf37. Genetic diversity of hepatitis C virus. Lopez-Osorio et al 2022.pdfArtículo publicado en revista indexadaapplication/pdf2699357https://repository.ucc.edu.co/bitstreams/1e2e47d0-90e1-4756-8316-695b5fa724bc/download193691fdd55e83b5e42bd163d8138dc7MD51Licencia de uso RI Ver5 - 9-07-2021. Genetic diversity of hepatitis c virus.pdfLicencia de uso RI Ver5 - 9-07-2021. Genetic diversity of hepatitis c virus.pdfLicencia de usoapplication/pdf195602https://repository.ucc.edu.co/bitstreams/5facfb08-e4dc-452c-9d36-392e9475fefb/downloadaeded09cc2c681c17fa50dbf22fbc6f7MD52LICENSElicense.txtlicense.txttext/plain; charset=utf-81748https://repository.ucc.edu.co/bitstreams/652d4dc3-7e4f-45a7-8c49-fa14ff1a9d52/download8a4605be74aa9ea9d79846c1fba20a33MD53THUMBNAIL37. Genetic diversity of hepatitis C virus. Lopez-Osorio et al 2022.pdf.jpg37. Genetic diversity of hepatitis C virus. Lopez-Osorio et al 2022.pdf.jpgGenerated Thumbnailimage/jpeg5531https://repository.ucc.edu.co/bitstreams/f31d20ce-50d7-4344-b7c4-197eb2cf9e06/download02cda3a98ebd320b62f3837468b20046MD54Licencia de uso RI Ver5 - 9-07-2021. Genetic diversity of hepatitis c virus.pdf.jpgLicencia de uso RI Ver5 - 9-07-2021. Genetic diversity of hepatitis c virus.pdf.jpgGenerated Thumbnailimage/jpeg5242https://repository.ucc.edu.co/bitstreams/3e480bdc-9805-43b7-850f-349d56949482/download680e17ded7c1cdac78327cae8b2dfa1aMD55TEXT37. Genetic diversity of hepatitis C virus. Lopez-Osorio et al 2022.pdf.txt37. Genetic diversity of hepatitis C virus. Lopez-Osorio et al 2022.pdf.txtExtracted texttext/plain49248https://repository.ucc.edu.co/bitstreams/7af445a7-cae4-4b74-9b51-4d9328a51d56/downloadbf30c9eeff14f64ddcb81b82f96b1ebeMD56Licencia de uso RI Ver5 - 9-07-2021. Genetic diversity of hepatitis c virus.pdf.txtLicencia de uso RI Ver5 - 9-07-2021. Genetic diversity of hepatitis c virus.pdf.txtExtracted texttext/plain5843https://repository.ucc.edu.co/bitstreams/ec9225f1-664f-49d7-886e-347d1dd53886/download53605d5d528f120ea847fce1283da1b8MD5720.500.12494/46184oai:repository.ucc.edu.co:20.500.12494/461842024-08-10 22:49:21.458restrictedhttps://repository.ucc.edu.coRepositorio Institucional Universidad Cooperativa de Colombiabdigital@metabiblioteca.comTk9URTogUExBQ0UgWU9VUiBPV04gTElDRU5TRSBIRVJFClRoaXMgc2FtcGxlIGxpY2Vuc2UgaXMgcHJvdmlkZWQgZm9yIGluZm9ybWF0aW9uYWwgcHVycG9zZXMgb25seS4KCk5PTi1FWENMVVNJVkUgRElTVFJJQlVUSU9OIExJQ0VOU0UKCkJ5IHNpZ25pbmcgYW5kIHN1Ym1pdHRpbmcgdGhpcyBsaWNlbnNlLCB5b3UgKHRoZSBhdXRob3Iocykgb3IgY29weXJpZ2h0Cm93bmVyKSBncmFudHMgdG8gRFNwYWNlIFVuaXZlcnNpdHkgKERTVSkgdGhlIG5vbi1leGNsdXNpdmUgcmlnaHQgdG8gcmVwcm9kdWNlLAp0cmFuc2xhdGUgKGFzIGRlZmluZWQgYmVsb3cpLCBhbmQvb3IgZGlzdHJpYnV0ZSB5b3VyIHN1Ym1pc3Npb24gKGluY2x1ZGluZwp0aGUgYWJzdHJhY3QpIHdvcmxkd2lkZSBpbiBwcmludCBhbmQgZWxlY3Ryb25pYyBmb3JtYXQgYW5kIGluIGFueSBtZWRpdW0sCmluY2x1ZGluZyBidXQgbm90IGxpbWl0ZWQgdG8gYXVkaW8gb3IgdmlkZW8uCgpZb3UgYWdyZWUgdGhhdCBEU1UgbWF5LCB3aXRob3V0IGNoYW5naW5nIHRoZSBjb250ZW50LCB0cmFuc2xhdGUgdGhlCnN1Ym1pc3Npb24gdG8gYW55IG1lZGl1bSBvciBmb3JtYXQgZm9yIHRoZSBwdXJwb3NlIG9mIHByZXNlcnZhdGlvbi4KCllvdSBhbHNvIGFncmVlIHRoYXQgRFNVIG1heSBrZWVwIG1vcmUgdGhhbiBvbmUgY29weSBvZiB0aGlzIHN1Ym1pc3Npb24gZm9yCnB1cnBvc2VzIG9mIHNlY3VyaXR5LCBiYWNrLXVwIGFuZCBwcmVzZXJ2YXRpb24uCgpZb3UgcmVwcmVzZW50IHRoYXQgdGhlIHN1Ym1pc3Npb24gaXMgeW91ciBvcmlnaW5hbCB3b3JrLCBhbmQgdGhhdCB5b3UgaGF2ZQp0aGUgcmlnaHQgdG8gZ3JhbnQgdGhlIHJpZ2h0cyBjb250YWluZWQgaW4gdGhpcyBsaWNlbnNlLiBZb3UgYWxzbyByZXByZXNlbnQKdGhhdCB5b3VyIHN1Ym1pc3Npb24gZG9lcyBub3QsIHRvIHRoZSBiZXN0IG9mIHlvdXIga25vd2xlZGdlLCBpbmZyaW5nZSB1cG9uCmFueW9uZSdzIGNvcHlyaWdodC4KCklmIHRoZSBzdWJtaXNzaW9uIGNvbnRhaW5zIG1hdGVyaWFsIGZvciB3aGljaCB5b3UgZG8gbm90IGhvbGQgY29weXJpZ2h0LAp5b3UgcmVwcmVzZW50IHRoYXQgeW91IGhhdmUgb2J0YWluZWQgdGhlIHVucmVzdHJpY3RlZCBwZXJtaXNzaW9uIG9mIHRoZQpjb3B5cmlnaHQgb3duZXIgdG8gZ3JhbnQgRFNVIHRoZSByaWdodHMgcmVxdWlyZWQgYnkgdGhpcyBsaWNlbnNlLCBhbmQgdGhhdApzdWNoIHRoaXJkLXBhcnR5IG93bmVkIG1hdGVyaWFsIGlzIGNsZWFybHkgaWRlbnRpZmllZCBhbmQgYWNrbm93bGVkZ2VkCndpdGhpbiB0aGUgdGV4dCBvciBjb250ZW50IG9mIHRoZSBzdWJtaXNzaW9uLgoKSUYgVEhFIFNVQk1JU1NJT04gSVMgQkFTRUQgVVBPTiBXT1JLIFRIQVQgSEFTIEJFRU4gU1BPTlNPUkVEIE9SIFNVUFBPUlRFRApCWSBBTiBBR0VOQ1kgT1IgT1JHQU5JWkFUSU9OIE9USEVSIFRIQU4gRFNVLCBZT1UgUkVQUkVTRU5UIFRIQVQgWU9VIEhBVkUKRlVMRklMTEVEIEFOWSBSSUdIVCBPRiBSRVZJRVcgT1IgT1RIRVIgT0JMSUdBVElPTlMgUkVRVUlSRUQgQlkgU1VDSApDT05UUkFDVCBPUiBBR1JFRU1FTlQuCgpEU1Ugd2lsbCBjbGVhcmx5IGlkZW50aWZ5IHlvdXIgbmFtZShzKSBhcyB0aGUgYXV0aG9yKHMpIG9yIG93bmVyKHMpIG9mIHRoZQpzdWJtaXNzaW9uLCBhbmQgd2lsbCBub3QgbWFrZSBhbnkgYWx0ZXJhdGlvbiwgb3RoZXIgdGhhbiBhcyBhbGxvd2VkIGJ5IHRoaXMKbGljZW5zZSwgdG8geW91ciBzdWJtaXNzaW9uLgo= |